2nd Quarter - Report

MILLER STRATEGIES, LLC for AMGEN, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Immigration IMM

Issues related to visas

LobbyistCovered position, as disclosed
ASHLEY GUNN —
JEFFREY MILLER —

Health Issues HCR

Healthcare policy issues as they relate to the pharmaceutical industry including drug pricing and biosimilars

LobbyistCovered position, as disclosed
ASHLEY GUNN —
JEFFREY MILLER —

Medicare/Medicaid MMM

Issues related to drug pricing, biosimilars, Medicare Part D and Medicare Part B; H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021

LobbyistCovered position, as disclosed
ASHLEY GUNN —
JEFFREY MILLER —

Bills named: H.R. 3517 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.